申请人:Boehringer Ingelheim GmbH
公开号:US03941789A1
公开(公告)日:1976-03-02
Compounds of the formula ##EQU1## wherein R is phenyl; phenyl having one or more substituents attached thereto, said substituents being selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, halogen and trifluoromethyl; a bicyclic aromatic or cycloaliphatic-aromatic ring, especially naphthyl, tetrahydronaphthyl or indanyl; or a mono- or bicyclic heterocyclic ring, especially pyridyl, pyrimidyl, isoquinolyl or thiazolyl; R.sub.1 is ##EQU2## where B is ##EQU3## n is 2, 3 or 4, R.sub.3 is hydrogen, alkyl of 1 to 4 carbon atoms or alkanoyl of 1 to 4 carbon atoms, R.sub.4 and R.sub.5, which may be identical to or different from each other, are each hydrogen or alkyl of 1 to 4 carbon atoms, p is 0 or 1, and Q is oxygen or two hydrogens, R.sub.2 is hydrogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, A is a single carbon-to-carbon bond or --OCH.sub.2 --, R.sub.6 is hydrogen, hydroxyl, alkoxy of 1 to 4 carbon atoms or alkanoyloxy of 1 to 4 carbon atoms, and m is 0, 1, 2, 3, 4 or 5, but other than 0 when R.sub.6 is hydroxyl, And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as CNS-depressants, adrenolytics, antiphologistics, analgesics, antihistamines and anticholesterols.
化合物的公式为##EQU1##其中R是苯基;苯基上有一个或多个取代基,所述取代基选择自1至4个碳原子的烷基,1至4个碳原子的烷氧基,1至4个碳原子的烷硫基,卤素和三氟甲基;一个双环芳香族或环烷基-芳香族环,特别是萘基,四氢萘基或茚基; 或者是一个单环或双环杂环,特别是吡啶基,嘧啶基,异喹啉基或噻唑基; R.sub.1是##EQU2##其中B是##EQU3##n是2、3或4,R.sub.3是氢,1至4个碳原子的烷基或1至4个碳原子的脂肪酰基,R.sub.4和R.sub.5,它们可以相同也可以不同,都是氢或1至4个碳原子的烷基,p是0或1,Q是氧或两个氢,R.sub.2是氢,1至4个碳原子的烷基,1至4个碳原子的烷氧基或卤素,A是单个碳-碳键或--OCH.sub.2 --,R.sub.6是氢,羟基,1至4个碳原子的烷氧基或1至4个碳原子的脂肪酰氧基,m是0、1、2、3、4或5,但当R.sub.6是羟基时,m不为0,并且其非毒性、药理学上可接受的酸盐;这些化合物及其盐可用作中枢神经系统抑制剂、肾上腺素能拮抗剂、抗炎剂、镇痛剂、抗组胺剂和降胆固醇剂。